Achieving approval for cancer treatments is fraught with challenges:
High Costs: The entire process, from preclinical research to clinical trials, is extremely expensive. Time-Consuming: The approval process can take several years, which is daunting for patients awaiting new treatments. Complex Regulation: Navigating the regulatory landscape requires significant expertise and resources. Variable Standards: Different countries have different approval standards, making global approval a complex endeavor.
